Umbelliferone

Catalog No.S3675 Synonyms: 7-hydroxycoumarin, hydrangine, skimmetine, beta-umbelliferone

For research use only.

Umbelliferone (7-hydroxycoumarin, hydrangine, skimmetine, beta-umbelliferone) is a 7-hydroxycoumarin that is a pharmacologically active agent. It is a fluorescing compound used as a sunscreen agent and shows good inhibitions of DPPH, hydroxyl, superoxide anion and ABTS radicals with anti-inflammatory, anti-hyperglycaemic, molluscicidal and anti-tumor activities.

Umbelliferone Chemical Structure

CAS No. 93-35-6

Selleck's Umbelliferone has been cited by 1 Publication

Purity & Quality Control

Related Other Products

Biological Activity

Description Umbelliferone (7-hydroxycoumarin, hydrangine, skimmetine, beta-umbelliferone) is a 7-hydroxycoumarin that is a pharmacologically active agent. It is a fluorescing compound used as a sunscreen agent and shows good inhibitions of DPPH, hydroxyl, superoxide anion and ABTS radicals with anti-inflammatory, anti-hyperglycaemic, molluscicidal and anti-tumor activities.
In vitro

Treatment of KB cells with Umbelliferone (UMB), prevents and reduces the cell proliferation with the IC50--200 μM as well as induces loss of cell viability, morphology change and internucleosomal DNA fragmentation in a concentration dependent manner. UMB induces apoptosis in KB cells in a dose dependent manner. UMB has the potential to increase oxidative DNA damage in KB cells through DNA tail formation significantly. UMB brings a dose-dependent elevation of reactive oxygen species (ROS), which is evidenced by the DCF fluorescence, alters the mitochondrial membrane potential in KB cells. UMB exhibits anticancer effect on KB cell line with the increased generation of intracellular ROS, triggers oxidative stress mediated depolarization of mitochondria, which contributes cell death via DNA damage as well as cell cycle arrest at G0/G1 phase. UMB protects alcoholic fatty liver, detoxify reactive aldehyde, radiation mediated cellular damage in human blood lymphocytes, immuno modulators and treat vascular lesions[1].

In vivo Treatment with umbelliferone (60 and 90 mg/kg) causes a marked reduction of cellularity and eosinophil numbers in bronchoalveolar lavage fluids from asthmatic mice. In addition, a decrease in mucus production and lung inflammation are observed in mice treated with umbelliferone. A reduction of IL-4, IL-5, and IL-13, but not of IFN-γ, is found in bronchoalveolar lavage fluids of mice treated with umbelliferone. umbelliferone attenuates airway inflammation in a murine model of asthma[2]. Dietary administration of umbelliferone and esculetin significantly attenuates MPTP-induced neurotoxicity in the substantia nigra pars compacta but not striatum, as measured by tyrosine hydroxylase staining. Umbelliferone also prevents MPTP-dependent caspase 3 activation, an indicator of apoptosis, but does not inhibit monoamine oxidase activity[3].

Protocol (from reference)

Cell Research:[1]
  • Cell lines: KB cells
  • Concentrations: 0–500 μg/ml
  • Incubation Time: 24 h
  • Method: Cells are seeded in 6 or 12 well plates prior to the addition of UMB. The KB cells are incubates with UMB (0-500 μg/ml of KB cells) for 24 h.
Animal Research:[2]
  • Animal Models: BALB/c mice
  • Dosages: 30, 60 and 90 mg/kg
  • Administration: oral

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 162.14
Formula

C9H6O3

CAS No. 93-35-6
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles C1=CC(=CC2=C1C=CC(=O)O2)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Umbelliferone | Umbelliferone supplier | purchase Umbelliferone | Umbelliferone cost | Umbelliferone manufacturer | order Umbelliferone | Umbelliferone distributor